"ovarian borderline tumor histologic" trang 11 - tải miễn phí từ tailieunhanh
Acceptability of quality indicators for the management of endometrial, cervical and ovarian cancer: Results of an online survey

Acceptability of quality indicators for the management of endometrial, cervical and ovarian cancer: Results of an online survey
9    53    2
An exploration of factors affecting the quality of life of women with primary ovarian insufficiency: A qualitative study

An exploration of factors affecting the quality of life of women with primary ovarian insufficiency: A qualitative study
9    59    2
Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers

Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
11    37    1
The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: A retrospective study

The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: A retrospective study
10    36    1
Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: An observational study

Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: An observational study
12    45    1
Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer

Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
13    25    1
Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer

Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer
11    42    1
Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms

Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms
10    43    1
Management and prognosis of patients with ovarian sex cord tumor with annular tubules: A retrospective study

Management and prognosis of patients with ovarian sex cord tumor with annular tubules: A retrospective study
8    28    1
Combined comparative genomic hybridization and transcriptomic analyses of ovarian granulosa cell tumors point to novel candidate driver genes

Combined comparative genomic hybridization and transcriptomic analyses of ovarian granulosa cell tumors point to novel candidate driver genes
11    47    1
Investigating the performance and costeffectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): Protocol of a prospective multicenter cohort study in the Netherlands

Investigating the performance and costeffectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): Protocol of a prospective multicenter cohort study in the Netherlands
6    49    1
High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
8    29    1
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
13    24    1
Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing

Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing
9    38    1
Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas

Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas
12    31    1
Prediction of resistance to chemotherapy in ovarian cancer: A systematic review

Prediction of resistance to chemotherapy in ovarian cancer: A systematic review
32    51    1
Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients

Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients
8    23    1
Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome

Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome
16    30    1
A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer
7    42    1
Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers
14    27    1